Filter
1392
Text search:
vaccine
doses
Featured
151
347
Language
Document type
589
255
237
77
77
70
37
23
11
9
3
3
1
Countries / Regions
78
62
34
32
30
27
25
25
24
23
22
21
21
20
20
19
19
18
17
17
16
15
15
14
12
12
12
12
10
10
10
9
9
8
8
8
7
7
7
7
6
6
6
5
5
5
5
4
4
4
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
589
174
95
57
33
10
7
1
Toolboxes
293
49
44
44
43
41
36
35
34
29
28
28
25
20
17
15
15
14
12
9
8
6
4
1
2nd edition .
This Framework applies to the sharing of H5N1 and other influenza viruses with human pandemic potential and the sharing of benefits. This Framework does not apply to seasonal influenza viruses or other non-influenza pathogens or biological substances that may be contained in clinical
...
Rewiew Article
Hindawi Publishing Corporation, Tuberculosis Research and Treatment; Volume 2011, Article ID 712736, 6 pages, doi:10.1155/2011/712736
This is an updated introductory two-page document that defines AIDS vaccines and reviews key developments in the field.
Presentations and agenda of the meeting held to update industry on the COVAX Facility and Gavi’s support for cold chain equipment (CCE) for COVID-19 vaccines.
at the World Trade Organization (WTO) Trade Related Aspects of Intellectual Property Rights (TRIPs) Council
23 Febur. 2021
Information sheet about coronavirus vaccination
recommended
Die Johanniter haben im Rahmen ihrer Aktivitäten im Bereich Flüchtlingshilfe und Integration allgemeine, niedrigschwellige Informationen zum Thema Corona-Impfung in verschiedenen Sprachen bereitgestellt. Diese dienen als Ergänzung zu den offiziellen Informationsmaterialien der Bundeszentrale für
...
This inter-agency guidance document aims to supplement the COVAX demand creation package for COVID-19 vaccines with key considerations for humanitarian contexts and marginalized populations with specific access and communication needs.
21 Sept.2021
This issue is available in Engilsh, Maguindanao, Maranao, Tagalog from the website
The updates are based on evidence emerging from the: Ongoing monitoring of the disease. Protection that the population already developed against COVID-19 through previous infection or vaccination. Epidemiological situation, availability of diagnostic tests and access to therapeutic options.
Guide; revised 15 June 2010
